学术报告题目：Structure-Based Drug Design and Discovery of Phosphodiesterase-5 Inhibitors for Treatment of Human Disease

报告人：Prof. Hengming Ke (柯衡明)

Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, USA

时间：2017年4月28日（星期五）上午10:30

地点：第六教学楼 222会议室 

报告人简介：

Prof Hengming Ke (Research Field: X-ray Protein Crystallography and Biochemistry)

1976: B.S. from Zhongshan University

1989: Ph.D. from Harvard University

1990-2000: Associate Professor, University of North Carolina at Chapel Hill

2001-Present: Professor, University of North Carolina at Chapel Hill

His research focuses on the structure and function of medically important proteins, and structure-based design of inhibitors for treatment of human diseases. The current topics include enzymatic and structural characterization of cyclic nucleotide phosphodiesterases (PDEs), structure-based design of PDE selective inhibitors, and discovery of novel metallo-β-lactamase (MBL) inhibitors to fight against superbugs.

Group Page: http://www.med.unc.edu/biochem/people/faculty/primary/ke